Chancery Warns EpicentRx About 'Flouted' Case Deadlines
A Delaware Chancery Court vice chancellor stopped short on Friday of penalizing clinical-stage biopharma company EpicentRx Inc. for what rival litigant Prothex Inc. called a "pattern" of missed deadlines in a...To view the full article, register now.
Already a subscriber? Click here to view full article